Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.

Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern closely linked to metabolic disorders, including obesity, insulin resistance, and dyslipidemia. Emerging evidence suggests that the gut-liver axis plays a critical role in the pathogenesis of NAFLD, with recent research highlighting the influence of gut microbiota, including fungal species such as Saccharomyces boulardii (). This study aimed to evaluate the effects of on lipid metabolism and oxidative stress in a rat model of fructose-induced NAFLD.